TY - JOUR
T1 - Long-term outcome after hand and forearm transplantation – a retrospective study
AU - Hautz, Theresa
AU - Messner, Franka
AU - Weissenbacher, Annemarie
AU - Hackl, Hubert
AU - Kumnig, Martin
AU - Ninkovic, Marina
AU - Berchtold, Valeria
AU - Krapf, Johanna
AU - Zelger, Bettina G.
AU - Zelger, Bernhard
AU - Wolfram, Dolores
AU - Pierer, Gerhard
AU - Löscher, Wolfgang N.
AU - Zimmermann, Robert
AU - Gabl, Markus
AU - Arora, Rohit
AU - Brandacher, Gerald
AU - Margreiter, Raimund
AU - Öfner, Dietmar
AU - Schneeberger, Stefan
N1 - Publisher Copyright:
© 2020 The Authors. Transplant International published by John Wiley & Sons Ltd on behalf of Steunstichting ESOT
PY - 2020/12
Y1 - 2020/12
N2 - Between 2000 and 2014, five patients received bilateral hand (n = 3), bilateral forearm (n = 1), and unilateral hand (n = 1) transplants at the Innsbruck Medical University Hospital. We provide a comprehensive report of the long-term results at 20 years. During the 6–20 years follow-up, 43 rejection episodes were recorded in total. Of these, 27.9% were antibody-related with serum donor-specific alloantibodies (DSA) and skin-infiltrating B-cells. The cell phenotype in rejecting skin biopsies changed and C4d-staining increased with time post-transplantation. In the long-term, a change in hand appearance was observed. The functional outcome was highly depending on the level of amputation. The number and severity of rejections did not correlate with hand function, but negatively impacted on the patients´ well-being and quality of life. Patient satisfaction significantly correlated with upper limb function. One hand allograft eventually developed severe allograft vasculopathy and was amputated at 7 years. The patient later died due to progressive gastric cancer. The other four patients are currently rejection-free with moderate levels of immunosuppression. Hand transplantation remains a therapeutic option for carefully selected patients. A stable immunologic situation with optimized and individually adopted immunosuppression favors good compliance and patient satisfaction and may prevent development of DSA.
AB - Between 2000 and 2014, five patients received bilateral hand (n = 3), bilateral forearm (n = 1), and unilateral hand (n = 1) transplants at the Innsbruck Medical University Hospital. We provide a comprehensive report of the long-term results at 20 years. During the 6–20 years follow-up, 43 rejection episodes were recorded in total. Of these, 27.9% were antibody-related with serum donor-specific alloantibodies (DSA) and skin-infiltrating B-cells. The cell phenotype in rejecting skin biopsies changed and C4d-staining increased with time post-transplantation. In the long-term, a change in hand appearance was observed. The functional outcome was highly depending on the level of amputation. The number and severity of rejections did not correlate with hand function, but negatively impacted on the patients´ well-being and quality of life. Patient satisfaction significantly correlated with upper limb function. One hand allograft eventually developed severe allograft vasculopathy and was amputated at 7 years. The patient later died due to progressive gastric cancer. The other four patients are currently rejection-free with moderate levels of immunosuppression. Hand transplantation remains a therapeutic option for carefully selected patients. A stable immunologic situation with optimized and individually adopted immunosuppression favors good compliance and patient satisfaction and may prevent development of DSA.
KW - complications
KW - donor-specific antibodies
KW - hand and forearm transplantation
KW - immunosuppression
KW - rejection
KW - vascularized composite allotransplantation
UR - http://www.scopus.com/inward/record.url?scp=85096780598&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096780598&partnerID=8YFLogxK
U2 - 10.1111/tri.13752
DO - 10.1111/tri.13752
M3 - Article
C2 - 32970891
AN - SCOPUS:85096780598
SN - 0934-0874
VL - 33
SP - 1762
EP - 1778
JO - Transplant International
JF - Transplant International
IS - 12
ER -